A Study in Adults With Geographic Atrophy (NCT07606365)
A Phase 2, Multicentre, Randomised, Double-masked, Placebo-controlled, Parallel-group, Dose-range Finding Study, to Assess the Efficacy and Safety of Oral STL303 in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD). Geographic atrophy secondary to AMD is a condition where cells in the back part of the eye slowly die, causing a blurry, or missing spot in the centre of vision.
Who can join: Review the eligibility criteria below.
Location: California Retina Consultants — Bakersfield, California
Age range: 60 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (60 Sites)
Showing the first 25 of 60 sites.
- California Retina Consultants — Bakersfield, California
- Retina-Vitreous Associates Medical Group — Beverly Hills, California
- Kaiser Permanente - Oakland — Oakland, California
- Retina Specialists of Colorado — Aurora, Colorado
- Retina Group of New England, PC — Waterford, Connecticut
- Retina Vitreous Associates of Florida — St. Petersburg, Florida
- Florida Retina Institute — Wildwood, Florida
- University Retina and Macula Associates, P.C. — Lemont, Illinois
- Associated Vitreoretinal and Uveitis Consultants — Carmel, Indiana
- Cumberland Valley Retina Consultants,P.C. — Hagerstown, Maryland
- Mid Atlantic Retina Specialists — Hagerstown, Maryland
- Ophthalmic Consultants of Boston — Waltham, Massachusetts
- Long Island and Queens Vitreoretinal Consultants of NY, P.C. — Hauppauge, New York
- Erie Retina Research — Erie, Pennsylvania
- Tennessee Retina, PC — Nashville, Tennessee
- Retina Consultants of Texas — Bellaire, Texas
- Star Vision Research — Burleson, Texas
- Retina Consultants of Texas — Schertz, Texas
- Northeast Wisconsin Retina Associates — Appleton, Wisconsin
- Eye Clinic of Wisconsin — Wausau, Wisconsin
- Buenos Aires Macula S.A — Buenos Aires, Buenos Aires
- Centro Medico Viamonte SRL — Buenos Aires, Buenos Aires
- Centro de Ojos Quilmes — Quilmes, Buenos Aires
- Hospital Britanico de Buenos Aires — Buenos Aires, Ciudad Autonoma Buenos Aires
- Instituoto Oftalmologico de Buenos Aires S.A. — Buenos Aires, Ciudad Autonoma Buenos Aires
📞 Contact the Study Coordinator
Phone: +41815602193
Email: studies@sitala.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Geographic Atrophy
- A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — Scottsdale, Arizona
- A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Bakersfield, California
- Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy — Phoenix, Arizona
- A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy — Gilbert, Arizona
- Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy — Phoenix, Arizona
Explore by condition: All Geographic Atrophy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.